Background. Atherosclerotic renovascular disease (ARVD) is commonly associated with renal failure.
Introduction
Atherosclerotic renovascular disease (ARVD) is a common cause of chronic renal failure (CRF) and many patients with end-stage renal disease (ESRD) also have ARVD w1x. Although with an ageing population the prevalence of this condition is increasing, the pathogenesis of CRF and the risk of progression to ESRD in patients with ARVD are not well established w2x.
Evidence now suggests that in the majority of patients with ARVD, the cause of CRF is unlikely to be due simply to the ischaemic effect of a proximal renal artery stenosis (RAS). Revascularization of a signi®cantly stenosed renal artery, whether this be with angioplasty with or without stenting, or by surgery, is accompanied by an unpredictable renal functional outcome, with only a minority of patients exhibiting improved renal function, but a similar proportion manifesting progressive functional deterioration w3x. Furthermore, a recent study has found no correlation between renal artery patency and glomerular ®ltration rate (GFR) in ARVD patients w4x.
It is likely, therefore, that parenchymal injury, with or without small-vessel disease, is the main determinant of renal dysfunction in most patients with ARVD. Such renal parenchymal injury has been termed`ischaemic nephropathy' w5x and histological changes include a constellation of interstitial ®brosis, tubular atrophy, glomerulosclerosis (including focal segmental glomerulosclerosis), periglomerular ®brosis, and a variety of arteriolar abnormalities. With the recognition that ischaemia is not always responsible for the CRF in patients with ARVD,`atherosclerotic nephropathy' has also recently been used to describe this intra-renal damage w6x. Many of these histological features are non-speci®c and are encapsulated by the term arterionephrosclerosis w7x, which can result from a variety of insults to the kidney, including hypertension and ischaemia. Such changes in the unaffected (non-RAS) kidney in ARVD are likely to be important in the pathogenesis of CRF, and this is borne out by isotopic techniques that estimate individual kidney function w8x.
The clinical signi®cance of the various renal histological abnormalities in patients with ARVD is unknown. Investigation is dif®cult largely because renal biopsies are not regularly or systematically obtained in these patients. In this study we investigated the impact of histological changes upon renal functional outcome in a group of patients whose renal biopsy appearances were compatible with ischaemic or atherosclerotic nephropathy, irrespective of whether or not signi®cant ARVD had been demonstrated at angiography.
Subjects and methods

Patient population
The Hope Hospital renal pathology database (1985±1998) was interrogated for patients with renal biopsy ®ndings compatible with atherosclerotic nephropathy. These changes included angionephrosclerosis with interstitial ®brosis, with or without ischaemic collapse of glomerular capillaries, and atheroembolic disease. All renal biopsies had been performed for investigation of unexplained proteinuria or renal impairment. Patients with renal biopsies that showed mild±moderate vascular changes alone, in keeping only with hypertensive damage, and those with evidence of another primary renal disease, such as diabetic nephropathy, were excluded from the study. The case notes of the appropriate patients were retrieved and data extracted from them.
Clinical data collection and end-points
Data collection was retrospective and included timed 24-h urine collections with corresponding serum samples used to measure creatinine clearance and proteinuria. Baseline characteristics were noted at the time of renal biopsy and renal functional outcome was assessed by change in creatinine clearance per year (DCrCl (mluminuyear)) over the follow-up period. Where renal angiograms had been performed the presence of aortic atheroma, as shown by the presence of aortic plaques (graded as mild, moderate, or severe) and signi®cant RAS ()50% stenosis) were noted by two independent clinicians blinded to the clinical information. Blood pressure at the beginning and the end of the follow-up period was recorded. Clinical endpoints were death, commencement of dialysis, or the last clinic visit data of those surviving patients with chronic renal failure.
Histological analysis
Histopathological ®ndings in the renal biopsies were analysed by three independent pathologists who were blinded to the clinical information. Two separate techniques were used to quantitatively assess the severity of histological injury.
Morphometric analysis. The proportional interstitial volume was determined using a Chalkley graticule (Graticules Ltd, Tonbridge, UK). The entire renal cortex was analysed for each biopsy, excluding ®elds that contained large arteries. As no biopsy showed oedema, interstitial volume was a measure of the extent of interstitial ®brosis. The number of globally sclerosed glomeruli in each biopsy was counted and expressed as a percentage of the total.
Semi-quantitative analysis. The extent of glomerulosclerosis, interstitial ®brosis, tubular atrophy, and arteriolar hyalinosis was assessed semi-quantitatively and scored variously 0±3 (Table 1 ). The total score for each biopsy was also calculated (`chronic damage score', maximums12). The chronic damage score was a modi®ed version of the Banff classi®cation of renal allograft pathology w9x. The median score for each histological parameter was derived from the assessments of all three pathologists for each patient. Where assessments were clearly discordant, the slides were reviewed and a consensus score identi®ed.
De®nition of renal functional stability or deterioration
In order to establish whether renal functional outcome was related to the extent of histological injury, patients were strati®ed into two groups based upon DCrCl over the 
Statistical analysis
Statistical methods were employed to establish whether there were signi®cant differences in the demographic, clinical and histopathological ®ndings between those patients with deteriorating and those with stable renal function. Data sets following a normal distribution (age, renal function, blood pressure, and interstitial volume measurements) were described in terms of their mean and standard deviation (SD). Data that did not follow a normal distribution (semiquantitative histological scores) and proteinuria were described in terms of the median value and interquartile range (IQR). One-way ANOVA tests were used to test signi®cance between continuous data sets. Unpaired nonnormal data was analysed using the Mann±Whitney U test. Pearson's correlation coef®cient was used to test whether any signi®cant association existed between renal functional outcome and histological injury in the entire patient population. A statistical difference was considered signi®cant at a level of P-0.05.
Results
Clinical features
Twenty-®ve patients (age 64.7"10.5, range 43±83, years; 17 male, eight female) were identi®ed as having biopsies consistent with atherosclerotic nephropathy. Angiography had been performed in 16 patients and this revealed aortic atheroma in all cases. Of these, two had mild atheroma, 12 had moderate atheroma, of whom two had signi®cant RAS, (one patient had unilateral right RAS, the other RAS in a solitary kidney), and two had severe atheroma but no evidence of RAS. In all 25 patients the left kidney had been biopsied. The mean follow up period was 25.6"14.8 months (range 5±50). During this time, 14 patients had a declining renal function (DCrCl ±7.4"6.8 mluminuyear, group 1) and 11 patients stable renal function (DCrCl 4.8"7.0 mluminuyear, group 2). The follow-up periods were similar for the two groups (28.4"15.5 vs 22.1"13.9 months), but four patients in the group with declining renal function developed ESRD and required dialysis. The number of deaths was similar in the two groups (3 and 2 respectively), and causes of death were malignancy or respiratory failure (two of each in both groups) and myocardial infarction in the other patient.
The clinical characteristics of the two groups at the time of study entry are summarized in Table 2 . Age was similar, but group 1 patients who subsequently had progressive renal functional deterioration had worse renal function (CrCl 27.6"17.6 vs 36.0"33.9), greater proteinuria (1.2 vs 0.5 gu24 h) and higher systolic blood pressure (167.1"30.8 mmHg vs 150.6"37.8) compared with group 2 patients. However, none of these differences was statistically signi®cant.
Histopathological features
Using morphometric analysis, patients in group 1 showed a signi®cantly higher percentage of globally sclerosed glomeruli (51.6"25.1 vs 24.9"20.0; P-0.01) and a greater proportional interstitial volume (44.9"8.7 vs 33.9"9.5%; P-0.02) compared with those in group 2.
Signi®cant differences between the groups were found for the overall score (P-0.05) and for glomerulosclerosis (P-0.05) when scored semi-quantitatively. There were no signi®cant differences between the groups in scores for tubular atrophy, interstitial ®brosis, and arteriolar thickening.
Cholesterol emboli were seen in two biopsies, one in each group. Ischaemic collapse of glomerular capillaries was seen in the biopsies of ®ve patients, of which three had worsening renal function. Chronic in¯am-matory cell in®ltration within the interstitium was seen in ®ve of the biopsies in group 1 patients, in one case this in®ltrate involved more than 25 per cent of the interstitium. Correlation studies performed in all 25 patients showed statistically signi®cant correlations between renal functional outcome (DCrCl) and the overall chronic damage score (Figure 1 ), percentage glomerulosclerosis (Figure 2) , and also proportional interstitial volume (Figure 3) .
In those 16 patients who had undergone angiography, there was an equal distribution of aortic atheroma severity in the two groups. Examples of the typical histopathological changes investigated within this study are shown in Figures 4±6.
Discussion
The pathogenesis of chronic renal failure in ARVD is not fully understood. The haemodynamic effect of a signi®cant proximal RAS can undoubtedly lead to a decrease in renal perfusion, intra-renal ischaemia, and progressive renal dysfunction in a proportion of patients. However, these are probably that minority of patients whose renal function improves after angioplasty w10,11x, stenting w12,13x, or surgical revascularization w14x. In the majority of patients with ARVD, renal function remains stable, or deteriorates, after revascularization w3x and residual renal artery patency appears to be unrelated to renal function w4x, the notable exceptions being those patients with renalartery occlusion (RAO) affecting either or both kidneys w15x. This suggests that renal parenchymal injury may be a more important factor in determining the renal functional outcome in patients with ARVD than was previously recognized.
Apart from the variable functional outcomes after revascularization procedures, further insight into the importance of parenchymal injury has been provided by isotopic studies that reliably estimate individual kidney function w8x. Thus, single-kidney GFR is often similarly decreased in both the contralateral`normal' kidney and the kidney with a signi®cant RAS within the same patient. The fact that proteinuria rises signi®cantly with decreasing renal function in ARVD patients w16x lends further support, as here proteinuria is likely to be a marker of severity of parenchymal damage.
The renal histological abnormalities in ARVD patients have been described previously w5x, but reports have usually focused on those kidneys with signi®cant RAS or RAO. There is now overwhelming evidence that damage often also occurs within the contralateral kidney that is unaffected by RAS. The importance of these histological changes in determining the outcome in ARVD has rarely been investigated, as renal biopsies are not systematically performed in patients with ARVD. When biopsy does take place, it is usually from the affected kidney in order to assess the severity of intra-renal damage during consideration of the value of revascularization w17x. Histological changes compatible with`atherosclerotic nephropathy' are nonspeci®c and are recognized in patients who do not have signi®cant RAS. For example, arteriosclerosis and arteriolosclerosis have been found in the absence of, or anticipating the onset of, hypertension, in young African black patients and in some animal models, leading to the hypothesis that some vascular nephropathies stem from a genetic defect w7x. We would anticipate, therefore, that in patients with atheroma, changes of atherosclerotic nephropathy are likely to occur in kidneys both affected and unaffected by signi®cant RAS. Hence, in this study, in order to assess the impact of the severity of such histological changes upon renal functional outcome, the main selection criterion was a renal biopsy diagnosis consistent with atherosclerotic nephropathy rather than angiographically proven ARVD. Indeed, in the 16 patients who did undergo angiography, all had evidence of aortic atheroma, two had peripheral vascular disease, and only two patients had signi®cant RAS.
After separating the patients with atherosclerotic nephropathy into two groups, based upon renal functional outcome, we identi®ed differences in certain clinical parameters between the groups. Those patients whose renal function deteriorated over the follow-up period had worse initial renal function, and greater systolic blood pressure and proteinuria at study entry than the patients with subsequent stable renal function. Although not statistically signi®cant, these differences in clinical parameters are similar to those that have been shown to affect progression of renal dysfunction in other chronic renal diseases w18x. Renal histological analysis, using two different quantitative techniques, revealed signi®cant overall differences between the two outcome groups. Patients in the declining renal function group had a higher proportion of both interstitial volume (and hence, interstitial ®brosis) and of glomerulosclerosis. Although the overall semi-quantitative chronic damage score can perhaps be considered artefactually derived, this was again signi®cantly higher in group 1 patients. Further, when the entire patient group was considered as a whole, there were signi®cant correlations between renal functional progression and the above histological parameters.
This study shows that in patients who have renal biopsies consistent with atherosclerotic nephropathy, the severity of histopathological damage will predict the probable renal functional prognosis. This correlation between biopsy ®ndings and renal functional outcome, by inference to the association of atherosclerotic nephropathy with ARVD, lends further support to renal parenchymal damage being an important determinant of renal functional outcome in patients with ARVD. However, we feel that it is now important to clarify whether, within the same patient with ARVD, the range of renal histological changes observed in a kidney affected by RAS can be differentiated from those within a kidney supplied by a patent renal artery. Future clinical studies will also need to focus on the impact of any such differential changes upon renal functional prognosis. With an ageing population, in whom ARVD is an increasingly recognized cause of ESRD, appreciation of this clinicopathological correlation is highly important and it may guide clinical management. For example, if a patient with signi®cant RAS were to have adverse histology in the contralateral kidney, then the clinician may be more inclined to consider revascularization of the RAS in order to prevent the development of ESRD.
